Viewing Study NCT00001060


Ignite Creation Date: 2025-12-25 @ 2:03 AM
Ignite Modification Date: 2026-06-30 @ 9:35 PM
Study NCT ID: NCT00001060
Status: COMPLETED
Last Update Posted: 2013-05-06
First Post: 1999-11-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase I Trial of HIV-1 C4-V3 Polyvalent Peptide Vaccine in HIV-1 Infected Persons
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HIV Infections View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Vaccines, Synthetic View
None HIV-1 View
None Acquired Immunodeficiency Syndrome View
None AIDS-Related Complex View
None AIDS Vaccines View
None HIV Therapeutic Vaccine View